Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 164.880
- +0.730+0.44%
Close Apr 28 16:00 ET
- 164.880
- 0.0000.00%
Post 16:05 ET
9.91BMarket Cap-22.23P/E (TTM)
167.370High161.610Low352.32KVolume164.150Open164.150Pre Close58.08MTurnover0.59%Turnover RatioLossP/E (Static)60.12MShares169.37052wk High-82.56P/B9.84BFloat Cap111.09052wk Low--Dividend TTM59.65MShs Float183.980Historical High--Div YieldTTM3.51%Amplitude11.920Historical Low164.836Avg Price1Lot Size
Ascendis Pharma A/S News
Earnings Preview: ASND to Report Financial Results Post-market on May 01
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading
Express News | Ascendis Pharma A/S : RBC Initiates Coverage With Outperform Rating; Price Target $205
Ascendis Pharma (ASND) Receives a Buy From Evercore ISI
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $192
There's Reason For Concern Over Ascendis Pharma A/S' (NASDAQ:ASND) Price
Ascendis Pharma Files New Drug Application for Achondroplasia Medication
UBS Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $196
Looking Into Ascendis Pharma's Recent Short Interest
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
J.P. Morgan Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $200
Ascendis Pharma Price Target Raised to $200.00/Share From $168.00 by JP Morgan
Ascendis Pharma Is Maintained at Overweight by JP Morgan
Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $181
Top Gap Ups and Downs on Monday: NFLX, NVO, NVS and More
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week
Wells Fargo Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $289
TD Cowen Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $162
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call